Biotech Next Gen 2021 has ended
avatar for Mark Hong

Mark Hong

Bryan, Garnier & Co
Healthcare Investment Banking Associate

Contact Me


My name is Mark Hong and I work with Phil Walker (Managing Director) in the Healthcare, Investment Banking division of Bryan Garnier & Co in London. Bryan, Garnier & Co is a full-service investment bank working with high growth European and US companies on the forefront of medical innovation, from founding to exit - covering Private Placements, IPOs and M&A. We are highly specialised in the healthcare space with one of the largest dedicated healthcare teams in Europe (including London) as well as offices in New York, Palo Alto and Shanghai.

We have been extremely active in the healthcare space over the last few months, raising funds for a wide range of companies headquartered across the UK, US, Scandinavia and France jurisdictions with investors in mainland Europe, the UK and the US. Some of the companies we have raised funds for over the last twelve months include: Valneva ($108M); Humangien ($100M); Gensight (€55M); Basilea (CHF 46M); Zealand (DKK749M); MedinCell (€47M); BioNTech ($669M). (https://www.bryangarnier.com/home/transactions/)

I would be very interested in learning more about your Company and if there is anything our team (including research analysts) could do to support you in taking the next step in growth. I look forward to connecting.